You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Bernstein Harold · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$400.46K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$29.81
Jul 1, 2026
First close after public filing
$32.35
Jul 6, 2026
30-day return after filing
-15.52%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13,409 shares @ $29.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050172-26-000025
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$589.09K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Exercise | Jul 1, 2026 | $152.23K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Jul 1, 2026 | $400.46K |
| Maze Therapeutics, Inc. MAZE | Sale | Jul 1, 2026 | $36.4K |
| Maze Therapeutics, Inc. MAZE | Exercise | Jul 1, 2026 | $0 |